Congratulations to @DanaFarber’s @judygarber5, recipient of the prestigious 2026 Basser Global Prize in recognition of her pioneering and transformative contributions to the treatment and understanding of BRCA-related cancers.

➡️bit.ly/47GHWn0

We’re pleased to share that Eliezer Van Allen, MD, of @VanAllenLab has been named our inaugural Chief Artificial Intelligence (AI) Officer (CAIO). Please join us in congratulating him on this new role.

Dana-Farber breaks ground on cancer hospital boston25news.com/news/local/dan…

We are now accepting applications for the T32 postdoctoral fellowship training program: Training in Oncology Population Sciences (TOPS)
 
Applications are due 12/16 and accepted fellows will begin their training in September 2027.  TOPSPostdoc.org

Marilyn Hammer, PhD, DC, RN, FAAN, director of @DanaFarber’s Cantor Center for Research and Patient Care Services, tells @OncNursingNews how its mission over the past 25 years has expanded to include precision health symptom science and health equity while bridging the gap between academic research and the clinical bedside. ➡️bit.ly/4vN5656

We're just getting started. Deconstruction is underway, and the newly installed wrap is a powerful glimpse of what’s ahead. It’s exciting to see this progress and take another step toward bringing our vision for the future of cancer care to life.

Today at #AACR26: Noah Fields, MS, of @DanaFarber’s @VanAllenLab, presents findings from a familial cancer study suggesting that high-resolution germline genetic testing could benefit patients with familial cancer.

➡️ bit.ly/4crIeQl

In a Phase II Clinical Trials poster session, @DanaFarber’s Dr. Catherine Marinac shares results from a clinical trial in MGUS and smoldering myeloma suggesting that short-term metformin may lead to modest improvements in M-protein levels. More research is needed to understand hese precursor blood disorders. #AACR26

➡️ bit.ly/48088JN

Today at #AACR26 @zeyun_lu, a research fellow in @SashaGusevPosts’s lab @DanaFarber, presents findings suggesting that large language model-based extraction of unstructured clinical notes can provide scalable and accurate characterization of immune-related side effects and prognosis. ➡️ bit.ly/4mxMtyF

Here's our latest, where we explored how to augment LLMs with constantly evolving precision oncology knowledge (h/t @moalmanac), followed by collaboration with medical oncologists to test their queries - congrats Helena Jun, et al!

Here's our latest, a perspective on the convergence of machine learning and genomics for precision oncology - exciting for 2026 and beyond! Congrats @brendan_reardon @AedinCulhane @NatureRevCancer

We're thrilled to launch a new postdoctoral research fellowship in oncology & health policy, jointly mentored by experts @DanaFarber & @SmithBIDMC

An incredible opportunity for scholars aiming to shape the future of cancer care and policy

Application➡️bit.ly/482xIgw

We are now accepting applications for the T32 postdoctoral fellowship training program called TOPS, Training in Oncology Population Sciences. Applications are due 12/17/25, and fellows will begin their training in Sept. 2026 TOPSPostdoc.org

The Division of Population Sciences @DFCIPopSci @DanaFarber @harvardmed is recruiting a new independent faculty member to establish a highly innovative research program geared toward improving cancer care - more info in the link and please share widely! careers.jamanetwork.com/job/110622822/…

Dana-Farber Cancer Institute and Northeastern University have teamed up on a new nursing education pipeline program, through which Dana-Farber nurses will become faculty members at the Boston school. bizjournals.com/boston/news/20…

Dr. Michael Hassett discusses the outcomes of an electronic patient-reported outcomes (#ePRO)–based #SymptomManagement Program (#eSyM) at #ASC025. #SIMPRO #PatientReportedOutcomes

Thinking about the way of the world, a chat ~25 years ago about a new camp for kids whose parents have cancer, and (soon-to-be) Dr. Jett Crowdis today

He shares his motivations in medicine, the link to @CampKesem, and our science in @Harvard Gazette
news.harvard.edu/gazette/story/…

False health information can lead to confusion and poor decisions. Vish Viswanath, PhD, shares insights on how to spot misinformation and find trusted sources.

Swipe for tips and learn more here: bit.ly/4iLFYoB

.@TODAYshow’s @craigmelvin reports from Dana-Farber, where Matthew Yurgelun, MD, director of the Lynch Syndrome Center, is leading groundbreaking research to find cancer before it spreads:
bit.ly/3XzbmP3

@DFarberYoungCRC #ColorectalCancerAwarenessMonth

Our new bulletin board is up, showcasing the work we’re doing in exercise oncology.
💡 What’s on the board?
✅ Info about our lab & mission
✅ Ongoing clinical trials
✅ How YOU can get involved!
Join us in redefining cancer care through movement. Exercise is Medicine! 💙